A bill to extend the limited antitrust exemption contained in the Pandemic and All-Hazards Preparedness Act.

(This measure has not been amended since it was introduced. The summary of that version is repeated here.)

Extends for one year the limited antitrust exemption under the Pandemic and All-Hazards Preparedness Act for participating in meetings and consultations to discuss security countermeasures, qualified countermeasures, or qualified pandemic or epidemic product development.